# Claims that COVID‑19 vaccine maker Moderna is developing an mRNA vaccine for hantavirus are circulating on social media.

*biotech · news · 2026-05-07 · Newsweek*

## Key points

- Moderna is only providing mRNA materials and technical support to Korea University's hantavirus project.
- The vaccine under development targets Asian hantavirus strains causing Hemorrhagic Fever with Renal Syndrome, not U.S. strains.
- There is no U.S. vaccination program or approved Moderna hantavirus vaccine initiative underway.
- Moderna’s vaccine research is unrelated to the Andes hantavirus outbreak on the Dutch cruise ship.

**Companies:** Moderna
**Countries:** South Korea, United States

[Read the full story on Newsweek](https://www.newsweek.com/did-moderna-start-developing-hantavirus-mrna-vaccine-in-2024-what-we-know-11924648)

---

Canonical: https://newsio.io/n/9156abe2-aba8-4459-bcf0-3c25d4d4fd3d/claims-that-covid19-vaccine-maker-moderna-is-developing-an-mrna-vaccine-for-hant
Summarized by Newsio from Newsweek. https://newsio.io/how-it-works